Recruiting

Spiritual Care Intervention in Adult Patients Diagnosed With Acute Leukemia

NCT07405424 · University of Chicago

Recruiting

In plain English

Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.

Official title

Spiritual Care to Optimize Relationships and Experience in Adults With Acute Leukemia (SCORE Trial)

About this study

This study is being done to determine if it is possible to incorporate spiritual care sessions as part of the care plan for patients hospitalized for leukemia treatment. In this study, participants will be randomly assigned to either no intervention (standard, real world inpatient spiritual care) or to receive study-specific guided spiritual sessions.

Eligibility criteria

Inclusion criteria * Adults (18 years or older) * Diagnosis of Acute Leukemia (AML or ALL) undergoing inpatient initial therapy * Ability to read, understand, and speak the English language * Ability to understand and the willingness to sign a written informed consent document Exclusion criteria * Unable to comply with spiritual care intervention * Relapsed or refractory acute leukemia * Cognitive deficits that limit participation and survey questionnaire completion

Study design

Enrollment target: 70 participants

Allocation: randomized

Masking: none

Age groups: adult, older_adult

Timeline

Starts: 2026-06-20

Estimated completion: 2028-06-16

Last updated: 2026-03-04

Interventions

Behavioral: SCORE Intervention

Primary outcomes

• Is it feasible to enroll patients to a spiritual intervention study? (End of study (approximately 2 years))
• Will patients accept using the study specific spiritual intervention? (End of study (approximately 2 years))

Sponsor

University of Chicago · other

Contacts & investigators

ContactClinical Trials Intake · contact · cancerclinicaltrials@bsd.uchicago.edu · 1-855-702-8222

InvestigatorWendy Stock · principal_investigator, University of Chicago

All locations (1)

UChicago Medicine Comprehensive Cancer CenterRecruiting

Chicago, Illinois, United States

View on ClinicalTrials.gov ↗Find similar trials